Metagenomics Market Size, Share, Growth, and Industry Analysis, By Type (Human Health,Environmental,Other), By Application (Sequencing and Data Analytics Services,Kits and Reagents,Other), Regional Insights and Forecast to 2035

Metagenomics Market Overview

The global Metagenomics Market size is projected to grow from USD 1208.53 million in 2026 to USD 1418.57 million in 2027, reaching USD 5112.17 million by 2035, expanding at a CAGR of 17.38% during the forecast period.

The Metagenomics Market continues to experience strong growth as next-generation sequencing (NGS) technologies expand across healthcare, agriculture, and environmental research sectors. Globally, over 21.6 million metagenomic sequencing runs were conducted in 2024, representing a 29.4% increase compared to 2022. The market’s technological infrastructure comprises over 5,700 sequencing facilities worldwide, with NGS platforms contributing 68% of data throughput. Around 41% of metagenomic studies target human health microbiomes, while 37% focus on environmental microbial ecosystems. Increasing adoption of bioinformatics and AI analytics has improved sequencing accuracy by 18.6%, reducing computational costs by 12.3% across research institutes.

In the United States, over 8.2 million sequencing-based metagenomic analyses were performed in 2024, accounting for 38% of global metagenomic data generation. The U.S. leads in clinical microbiome research, with 54% of projects funded by academic–industry collaborations. Over 600 hospitals and diagnostics labs have integrated metagenomic workflows for infectious disease identification, achieving average detection rates of 97.4%. Environmental metagenomics applications—especially wastewater and soil analysis—expanded by 22% between 2023 and 2025. The U.S. Metagenomics Market Outlook is further strengthened by over 1,300 ongoing projects under NIH and private research grants emphasizing human gut microbiota sequencing and antimicrobial resistance tracking.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: About 64% of metagenomic data generation growth is driven by advancements in sequencing automation and microbial genome analysis.
• Major Market Restraint: Around 35% of laboratories cite high sample preparation costs and lack of skilled bioinformatics expertise as limiting factors.
• Emerging Trends: Approximately 43% of new research focuses on clinical diagnostics and personalized medicine applications of metagenomics.
• Regional Leadership: North America holds 39% of global metagenomics studies, followed by Europe at 27%, and Asia-Pacific at 25%.
• Competitive Landscape: Top five industry players account for 58% of global sequencing volume and 61% of bioinformatics platform usage.
• Market Segmentation: Human health accounts for 41%, environmental metagenomics 37%, and other applications 22% of global datasets.
• Recent Development: Over 28% of laboratories adopted nanopore-based sequencing platforms between 2023–2025 for real-time microbial profiling.

Metagenomics Market Latest Trends

The Metagenomics Market Trends show a transformative shift toward real-time, portable sequencing platforms and high-throughput bioinformatics. In 2024, nearly 47% of global sequencing facilities adopted hybrid platforms combining short-read and long-read technologies for improved microbial diversity mapping. Cloud-based data processing accounted for 32% of total bioinformatics usage, reducing analysis time by 26%. Clinical diagnostics applications increased by 19%, while agricultural and environmental microbiome sequencing rose by 21% globally.

Metagenomic sequencing kits optimized for soil and wastewater microbiota characterization increased in production by 18.4%. Over 62% of research institutes employed AI-driven data interpretation models, enabling strain-level resolution of microbial communities. Additionally, 35% of pharmaceutical and biotechnology companies integrated metagenomic analytics into drug discovery pipelines. Portable sequencers and handheld diagnostic tools contributed to 12% of the total market installations. The Metagenomics Market Analysis indicates rapid standardization of sample preparation protocols—reducing contamination rates by 14%—and expanding applications across clinical, veterinary, and agricultural ecosystems.

Metagenomics Market Dynamics

DRIVER

"Expansion of Clinical Microbiome Research and Infectious Disease Diagnostics"

The increasing use of metagenomics in infectious disease diagnosis drives substantial Metagenomics Market Growth. In 2024, over 900 hospitals implemented metagenomic sequencing for pathogen detection. Clinical microbiome research represents 43% of total sequencing throughput. Hospitals using metagenomic diagnostics report identification accuracy of 96–99% for complex infections. Metagenomic data now contributes to 18% of antimicrobial resistance surveillance studies globally. The clinical research infrastructure supporting these applications grew by 17% between 2022–2024, supported by academic–industry partnerships.

RESTRAINT

"High Cost of Sample Preparation and Bioinformatics Infrastructure"

Despite growth, the Metagenomics Industry Report identifies cost barriers as a significant restraint. Sample extraction and library preparation represent 41% of total experiment costs. Computing and storage infrastructure expenses grew by 15% in 2024 due to rising data complexity. Approximately 34% of small laboratories report challenges in maintaining bioinformatics expertise for data interpretation. Sequencing error correction adds an extra 8–12 hours of processing time per dataset, limiting throughput efficiency.

OPPORTUNITY

"Growth in Environmental and Agricultural Microbiome Studies"

Environmental applications provide major Metagenomics Market Opportunities, representing 37% of total global activity. Soil, water, and wastewater metagenomics programs expanded by 24% in 2024. Over 1,200 active research projects analyze microbial communities in soil ecosystems to improve crop yields. Water microbiome surveillance initiatives across Asia and Europe increased by 22%, enhancing water quality management. Agricultural biotechnology companies have adopted metagenomics for soil fertility analysis, increasing precision-farming productivity by 11%.

CHALLENGE

"Data Overload and Lack of Standardized Analytical Pipelines"

One key challenge highlighted in the Metagenomics Industry Analysis is the lack of global standardization in data analysis pipelines. On average, each metagenomic project generates 2–4 terabytes of sequencing data, straining storage infrastructure. Only 39% of labs utilize standardized quality control protocols. Inconsistencies between bioinformatics tools cause 12–16% variation in species identification accuracy. As a result, 44% of organizations invest in in-house computational biology teams to manage data volume and enhance analytical precision.

Metagenomics Market Segmentation

The Metagenomics Market Segmentation is divided by type and application, reflecting the diversity of sequencing use cases across industries.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Human Health: The human health segment accounts for 41% of the global Metagenomics Market Size, driven by diagnostics, precision medicine, and microbiome therapeutics. In 2024, over 6.8 million human microbiome sequencing datasets were generated. Gut microbiome research projects increased by 26%, and clinical diagnostics accounted for 53% of all human metagenomic studies. Hospitals adopting metagenomic tests reduced diagnostic delays by 36%, significantly improving patient outcomes.

Environmental: Environmental metagenomics contributes 37% of total sequencing volume. Soil microbiome sequencing projects increased to 4.1 million datasets, representing a 19% growth from 2023. Marine and freshwater ecosystem analyses expanded by 22%, involving 1,800 research institutions worldwide. Airborne microbial surveillance studies grew by 17%, particularly in urban pollution monitoring. These applications play a vital role in ecosystem management, bioremediation, and industrial microbiology innovations.

Other: The “other” category represents 22% of the Metagenomics Market Share, including veterinary science, industrial fermentation, and synthetic biology. Over 1,600 labs utilize metagenomics for enzyme discovery and microbial strain improvement. Industrial biotechnology applications increased by 14%, with over 430 new enzyme families identified through sequencing between 2023–2025. Veterinary metagenomics projects expanded by 21%, advancing animal gut health and feed optimization research.

By Application

Sequencing and Data Analytics Services: Sequencing and analytics services dominate with 52% of market activity. In 2024, over 12 million sequencing runs were processed through commercial service providers. Contract research organizations (CROs) increased project capacity by 23%, handling complex metagenomic pipelines. Cloud-based computational analysis accounts for 36% of data processing volume. The Metagenomics Market Research Report notes that real-time analytics platforms improved data interpretation speeds by 27%, boosting clinical adoption.

Kits and Reagents: Kits and reagents represent 31% of market demand. Over 450 new reagent products were commercialized between 2023–2025 to support diverse sample types. DNA extraction kits designed for low-biomass samples increased performance yields by 18%. High-fidelity polymerase enzymes now provide sequencing accuracy above 99.3%. Laboratory automation platforms utilizing pre-filled reagent cartridges improved operational efficiency by 22%.

Other: The remaining 17% of the market includes hardware platforms, bioinformatics tools, and training services. Approximately 780 bioinformatics software solutions are currently active worldwide. Training programs for genomic data scientists expanded by 19%, certifying over 7,000 professionals globally. Integrated sequencing workstations reduced laboratory space needs by 25%, supporting adoption among smaller facilities.

Metagenomics Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America dominates the Metagenomics Market, accounting for 39% of global data output. The U.S. leads with 87% of regional activity, while Canada and Mexico contribute 9% and 4%, respectively. Over 2,400 sequencing facilities operate in North America. The number of metagenomics-focused research publications rose by 21% in 2024. Around 59% of hospitals have implemented metagenomic testing capabilities. Environmental metagenomics projects related to wastewater monitoring increased by 18%, improving public health surveillance. The U.S. National Microbiome Initiative supports 340+ research programs across academia and private sectors, driving technological adoption.

Europe

Europe holds 27% of the Metagenomics Market Share, supported by robust healthcare infrastructure and public research funding. The UK, Germany, and France contribute 73% of total sequencing operations. Over 1,700 active laboratories conduct metagenomic research across Europe. The European Bioinformatics Network processed 3.2 petabytes of metagenomic data in 2024. Around 48% of European universities now include microbiome research centers. Environmental metagenomics projects focusing on soil restoration and marine biodiversity grew by 19%. The adoption of nanopore sequencing increased by 24%, improving field-based data collection across environmental and health applications.

Asia-Pacific

Asia-Pacific accounts for 25% of global metagenomics studies. China leads with 42% of regional sequencing throughput, followed by Japan at 21%, India at 18%, and South Korea at 11%. Over 2,900 metagenomics projects were active in the region in 2024. Government-funded microbial genome programs grew by 28%. Soil and agricultural metagenomics research increased by 22%, supporting sustainable farming initiatives. Biotechnology firms in Japan and China collectively launched 85 new metagenomics-based products in 2024. The region’s Metagenomics Market Forecast shows expanding commercial sequencing centers, with 1,400 facilities currently operational.

Middle East & Africa

The Middle East & Africa represent 9% of global market volume. The UAE, Saudi Arabia, and South Africa lead with 71% of regional sequencing capacity. Around 320 laboratories operate in this region. Clinical metagenomics adoption increased by 17%, especially for infectious disease diagnostics. Environmental microbiome monitoring projects rose by 14%, with over 90 new initiatives in desert ecosystem analysis. The region saw 11% growth in metagenomics-based agricultural R&D focused on soil fertility improvement. Government investment in genomic medicine programs expanded by 22%, strengthening the Metagenomics Market Outlook across healthcare sectors.

List of Top Metagenomics Companies

• DNAstar Inc.
• Oxford Nanopore Technologies Ltd.
• Eurofins Scientific
• Aperiomics
• BGI Group
• GENEWIZ
• Illumina
• Thermo Fisher Scientific
• SciGenom Labs
• Agilent Technologies
• Enterome Bioscience
• Novogene Co. Ltd.
• Swift Biosciences
• Quest Diagnostics
• The MITRE Corporation
• Merck KGaA
• Pacific Biosciences of California
• Promega Connections
• PerkinElmer
• Bio-Rad Laboratories Inc.
• IntegraGen SA
• Qiagen NV
• Hoffmann-La Roche
• Macrogen Inc.

Top Companies by Market Share:

• Illumina – holds 21.7% of global market share, supporting over 12,000 sequencing systems in operation worldwide.
• Thermo Fisher Scientific – holds 18.4% share, with distribution networks spanning 120 countries and 7,800 operational genomic instruments.

Investment Analysis and Opportunities

Investments in the Metagenomics Market surged by 19% between 2023–2025, driven by technological innovations and expanding clinical applications. Approximately 44% of global investments target automation and AI integration in bioinformatics. Government-funded microbiome initiatives accounted for 38% of total spending. Over 520 start-ups specializing in metagenomic analytics received venture capital funding. Asia-Pacific attracted 42% of these new investments, while North America secured 36%.

Infrastructure development projects for sequencing and data centers expanded by 23% globally. Pharmaceutical companies increased their collaboration with metagenomics firms by 21% to accelerate antibiotic discovery and probiotic formulation. These trends represent significant Metagenomics Market Opportunities for emerging players in sequencing technology, data analytics, and precision health sectors.

New Product Development

Between 2023 and 2025, over 63 new metagenomic sequencing kits and 40 software platforms were launched globally. Illumina released high-throughput sequencing kits that increased read accuracy by 15%. Thermo Fisher Scientific developed AI-driven bioinformatics pipelines reducing data processing time by 22%. Oxford Nanopore Technologies introduced portable devices achieving 98% base-calling accuracy.

New reagent formulations enhanced sample recovery rates by 19% for low-biomass environments. Integrated systems combining sequencing and data analytics reduced project turnaround time by 27%. The Metagenomics Market Insights highlight growing trends in hybrid sequencing platforms and real-time pathogen identification tools, catering to clinical diagnostics, food safety, and agricultural microbiome research.

Five Recent Developments (2023–2025)

• Illumina (2025): Released a new sequencing kit with 25% faster throughput for microbiome profiling.
• Thermo Fisher (2024): Deployed automated metagenomic workflows across 450 diagnostic labs worldwide.
• Oxford Nanopore (2024): Introduced field-based sequencing device with data upload speeds 40% faster than previous models.
• BGI Group (2023): Opened a 60,000-sample capacity sequencing facility dedicated to environmental microbiome projects.
• Qiagen (2025): Launched advanced sample prep kits improving microbial DNA yield by 17% for soil and wastewater samples.

Report Coverage of Metagenomics Market

The Metagenomics Market Research Report offers an extensive overview of the global industry landscape across human health, environmental, and industrial segments. It covers over 24 leading companies and analyzes 25 market segments by type, application, and region. The report provides quantitative analysis based on sequencing throughput, laboratory adoption rates, and project volume metrics.

The Metagenomics Industry Analysis examines growth drivers such as AI integration, portable sequencing devices, and rising clinical microbiome research. It further evaluates barriers like high costs, bioinformatics skill shortages, and data standardization challenges. With over 300 verified data points, this Metagenomics Market Report delivers strategic insights into current market structures, emerging technologies, and future investment directions shaping global microbiome research and bioinformatics sectors.

Metagenomics Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1208.53 Million in 2026
Market Size Value By	USD 5112.17 Million by 2035
Growth Rate	CAGR of 17.38% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Human Health Environmental Other By Application : Sequencing and Data Analytics Services Kits and Reagents Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample